Caprock Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Caprock Group, Inc.

$4.08 Billion
Q3 2025

A detailed history of Caprock Group, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 2,528 shares of REGN stock, worth $1.64 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,528

Previous 1,195 111.55%

Holding current value

$1.64 Million

Previous $757,000 87.71%

% of portfolio

0.03%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$534.91 - $598.71 $713,035 - $798,080	1,333 Added 111.55%	2,528 $1.42 Million
Q1 2025 May 15, 2025	SELL	$634.14 - $744.83 $286,631 - $336,663	-452 Reduced 27.44%	1,195 $757,000
Q4 2024 Jan 23, 2025	BUY	$701.85 - $1046.91 $246,349 - $367,465	351 Added 27.08%	1,647 $1.17 Million
Q3 2024 Nov 07, 2024	SELL	$1024.09 - $1201.76 $92,168 - $108,158	-90 Reduced 6.49%	1,296 $1.36 Million
Q2 2024 Aug 06, 2024	BUY	$883.2 - $1071.19 $460,147 - $558,089	521 Added 60.23%	1,386 $1.46 Million
Q1 2024 Apr 29, 2024	BUY	$902.69 - $993.35 $61,382 - $67,547	68 Added 8.53%	865 $832,000
Q4 2023 Jan 18, 2024	SELL	$775.18 - $881.7 $118,602 - $134,900	-153 Reduced 16.11%	797 $699,000
Q3 2023 Oct 18, 2023	SELL	$692.45 - $844.37 $102,482 - $124,966	-148 Reduced 13.48%	950 $781,000
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $131,605 - $156,105	188 Added 20.66%	1,098 $788,000
Q1 2023 Apr 26, 2023	BUY	$680.49 - $826.97 $163,317 - $198,472	240 Added 35.82%	910 $747,000
Q4 2022 Jan 23, 2023	BUY	$705.89 - $766.39 $93,177 - $101,163	132 Added 24.54%	670 $0
Q3 2022 Nov 07, 2022	BUY	$573.97 - $724.32 $37,882 - $47,805	66 Added 13.98%	538 $371,000
Q2 2022 Jul 26, 2022	SELL	$548.35 - $738.84 $2,741 - $3,694	-5 Reduced 1.05%	472 $279,000
Q1 2022 Apr 12, 2022	BUY	$595.12 - $698.43 $23,804 - $27,937	40 Added 9.15%	477 $333,000
Q4 2021 Jan 18, 2022	SELL	$543.48 - $670.97 $7,065 - $8,722	-13 Reduced 2.89%	437 $276,000
Q3 2021 Oct 07, 2021	BUY	$574.03 - $680.96 $25,257 - $29,962	44 Added 10.84%	450 $272,000
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $191,956 - $226,767	406 New	406 $227,000
Q1 2021 Apr 29, 2021	SELL	$446.73 - $548.2 $190,306 - $233,533	-426 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$478.3 - $607.98 $69,831 - $88,765	-146 Reduced 25.52%	426 $206,000
Q3 2020 Oct 29, 2020	BUY	$544.75 - $658.21 $84,981 - $102,680	156 Added 37.5%	572 $320,000
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $205,221 - $267,870	416 New	416 $259,000

Others Institutions Holding REGN

# of Institutions

1,452

Shares Held

89.1M

Call Options Held

1.77M

Put Options Held

1.74M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $69.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History